KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:待检查

Real-World Data on the Use of Follitropin Delta in a Dutch IVF Center.

Pauline Boom, Eva C Creutzberg, Maria P H Koster, Joop S E Laven

Reprod Med Biol 25(1) e70050

PMID42253904
PMCIDPMC13238530
DOI10.1002/rmb2.70050
发表日期2026-06-08
AI 判定该论文不进入自动 KM 提取:The record is a descriptive analysis of real-world data, not a randomized controlled trial. It compares outcomes to a prior phase III trial but is not itself a phase III RCT.
摘要

摘要

RESEARCH QUESTION: How does follitropin delta administered with an individualized dose based on body weight and AMH perform in daily practice, and is this comparable to results from a randomized phase III clinical trial in terms of ovarian response, pregnancy, and safety? DESIGN: This is a descriptive analysis of real-world data obtained from the Erasmus University Medical Centre (EMC). Patients were treated with the dose of follitropin delta calculated according to the algorithm described in the ESTHER-1 trial. Outcome data were restricted to the first IVF cycle in patients with a regular ovulatory cycle treated with a GnRH antagonist protocol for whom the intended day of embryo transfer was day 5. RESULTS: The ongoing pregnancy rate was 30.8% per started cycle, which is equivalent to the ESTHER-1 trial. The number of oocytes retrieved (10.3 ± 5.4) was also comparable. All other ovarian response parameters were within the range that was expected on the basis of the results of the ESTHER-1 trial. CONCLUSIONS: The use of follitropin delta in a real-world clinical setting results in ovarian response outcomes comparable in range to those in the follitropin delta arm of the ESTHER-1 registration trial. No differences were observed in treatment outcomes.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。